Does DURVALUMAB Cause Disease progression? 255 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 255 reports of Disease progression have been filed in association with DURVALUMAB (IMFINZI). This represents 1.5% of all adverse event reports for DURVALUMAB.
255
Reports of Disease progression with DURVALUMAB
1.5%
of all DURVALUMAB reports
55
Deaths
29
Hospitalizations
How Dangerous Is Disease progression From DURVALUMAB?
Of the 255 reports, 55 (21.6%) resulted in death, 29 (11.4%) required hospitalization, and 3 (1.2%) were considered life-threatening.
Is Disease progression Listed in the Official Label?
Yes, Disease progression is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which DURVALUMAB Alternatives Have Lower Disease progression Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE